Macrolides in the modern therapy of community-acquired pneumonia in children
Community-acquired pneumonia remains one of the most pressing problems in pediatrics. The article presents data on its prevalence, child mortality from this disease, diagnostic criteria and approaches to therapy. In the Russian Federation, respiratory diseases in children aged 0-17 take third place...
Main Author: | Yu. L. Mizernitskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-11-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5898 |
Similar Items
-
Clinical features, diagnosis and treatment of respiratory M. pneumoniae infection in children
by: A. L. Zaplatnikov, et al.
Published: (2019-11-01) -
Macrolide-resistant <it>Mycoplasma pneumoniae</it> in adolescents with community-acquired pneumonia
by: Miyashita Naoyuki, et al.
Published: (2012-05-01) -
Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults
by: Sinopalnikov A.I., et al.
Published: (2019-12-01) -
Macrolides and their role in the treatment of community-acquired pneumonia of various etiology
by: I. V. Leschenko, et al.
Published: (2015-12-01) -
Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia
by: Roger Dumke, et al.
Published: (2014-12-01)